Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Koji Taniguchi | M | - |
ImmunoFrontier, Inc.
 ImmunoFrontier, Inc. Miscellaneous Commercial ServicesCommercial Services ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan. | - |
| Masanobu Fujiwara | M | - |
ImmunoFrontier, Inc.
ImmunoFrontier, Inc. Miscellaneous Commercial ServicesCommercial Services ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan. | - |
| Yasuhiro Tate | M | - |
ImmunoFrontier, Inc.
ImmunoFrontier, Inc. Miscellaneous Commercial ServicesCommercial Services ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan. | - |
| Toshikatsu Imai | M | - |
ImmunoFrontier, Inc.
ImmunoFrontier, Inc. Miscellaneous Commercial ServicesCommercial Services ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Japan | 4 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Hiroshi Miyamoto
- Persönliches Netzwerk
